Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387473447> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4387473447 abstract "Aim: To evaluate the availability of published comparative real-world evidence (RWE) studies in Medicare patients for the ten drugs set to undergo Centers for Medicare and Medicaid Services (CMS) price negotiations in 2026. Materials & methods: A scoping review was completed in MEDLINE/PubMed to evaluate the availability of comparative RWE investigations conducted among Medicare-eligible patient populations in the US for the following drugs: apixaban, rivaroxaban, sitagliptin, ibrutinib, empagliflozin, etanercept, dapagliflozin, sacubitril/valsartan, ustekinumab and insulin aspart. Results: Of the 170 real-world comparative studies identified, 55 (32.4%) used Medicare real-world data (RWD) while 34 (20.0%) used commercial claims data in conjunction with either Medicare Advantage or Medicare Supplementary databases. The number of studies varied considerably by drug with apixaban and rivaroxaban studies accounting for the majority (i.e., 67.1%) of comparative RWE studies. Approximately a third or less of the comparative RWE studies were conducted in CMS RWD per drug. Conclusion: Our results demonstrate there is a considerable amount of comparative RWE for apixaban, rivaroxaban, and etanercept but limited comparative RWE for the other drugs set to undergo CMS price negotiations in 2026; additionally, our findings set up a number of next steps (e.g., risk of bias assessments) for further exploration of the available evidence base. Overall, CMS and manufacturers should consider proactively generating high-quality comparative RWE studies in the Medicare population to ensure that future price negotiations are based on robust evidence." @default.
- W4387473447 created "2023-10-11" @default.
- W4387473447 creator A5034879617 @default.
- W4387473447 creator A5035942809 @default.
- W4387473447 creator A5086636394 @default.
- W4387473447 date "2023-10-10" @default.
- W4387473447 modified "2023-10-16" @default.
- W4387473447 title "Availability of comparative real-world evidence research in Medicare patients: implications for Centers for Medicare and Medicaid Services drug price negotiations" @default.
- W4387473447 cites W1572319397 @default.
- W4387473447 cites W2319983832 @default.
- W4387473447 cites W2531269403 @default.
- W4387473447 cites W2901669506 @default.
- W4387473447 cites W3014378002 @default.
- W4387473447 cites W3093085210 @default.
- W4387473447 cites W3182406429 @default.
- W4387473447 doi "https://doi.org/10.57264/cer-2023-0125" @default.
- W4387473447 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37815792" @default.
- W4387473447 hasPublicationYear "2023" @default.
- W4387473447 type Work @default.
- W4387473447 citedByCount "0" @default.
- W4387473447 crossrefType "journal-article" @default.
- W4387473447 hasAuthorship W4387473447A5034879617 @default.
- W4387473447 hasAuthorship W4387473447A5035942809 @default.
- W4387473447 hasAuthorship W4387473447A5086636394 @default.
- W4387473447 hasBestOaLocation W43874734471 @default.
- W4387473447 hasConcept C134018914 @default.
- W4387473447 hasConcept C142724271 @default.
- W4387473447 hasConcept C160735492 @default.
- W4387473447 hasConcept C162324750 @default.
- W4387473447 hasConcept C204787440 @default.
- W4387473447 hasConcept C2426938 @default.
- W4387473447 hasConcept C2776291444 @default.
- W4387473447 hasConcept C2776534028 @default.
- W4387473447 hasConcept C2777180221 @default.
- W4387473447 hasConcept C2777422806 @default.
- W4387473447 hasConcept C2778111679 @default.
- W4387473447 hasConcept C2778829437 @default.
- W4387473447 hasConcept C2778858636 @default.
- W4387473447 hasConcept C50522688 @default.
- W4387473447 hasConcept C555293320 @default.
- W4387473447 hasConcept C71924100 @default.
- W4387473447 hasConcept C98274493 @default.
- W4387473447 hasConceptScore W4387473447C134018914 @default.
- W4387473447 hasConceptScore W4387473447C142724271 @default.
- W4387473447 hasConceptScore W4387473447C160735492 @default.
- W4387473447 hasConceptScore W4387473447C162324750 @default.
- W4387473447 hasConceptScore W4387473447C204787440 @default.
- W4387473447 hasConceptScore W4387473447C2426938 @default.
- W4387473447 hasConceptScore W4387473447C2776291444 @default.
- W4387473447 hasConceptScore W4387473447C2776534028 @default.
- W4387473447 hasConceptScore W4387473447C2777180221 @default.
- W4387473447 hasConceptScore W4387473447C2777422806 @default.
- W4387473447 hasConceptScore W4387473447C2778111679 @default.
- W4387473447 hasConceptScore W4387473447C2778829437 @default.
- W4387473447 hasConceptScore W4387473447C2778858636 @default.
- W4387473447 hasConceptScore W4387473447C50522688 @default.
- W4387473447 hasConceptScore W4387473447C555293320 @default.
- W4387473447 hasConceptScore W4387473447C71924100 @default.
- W4387473447 hasConceptScore W4387473447C98274493 @default.
- W4387473447 hasLocation W43874734471 @default.
- W4387473447 hasLocation W43874734472 @default.
- W4387473447 hasOpenAccess W4387473447 @default.
- W4387473447 hasPrimaryLocation W43874734471 @default.
- W4387473447 hasRelatedWork W1491750104 @default.
- W4387473447 hasRelatedWork W1991467188 @default.
- W4387473447 hasRelatedWork W2081892859 @default.
- W4387473447 hasRelatedWork W2262682665 @default.
- W4387473447 hasRelatedWork W2334209872 @default.
- W4387473447 hasRelatedWork W2773239289 @default.
- W4387473447 hasRelatedWork W3147387082 @default.
- W4387473447 hasRelatedWork W3150411697 @default.
- W4387473447 hasRelatedWork W3150558171 @default.
- W4387473447 hasRelatedWork W4291988152 @default.
- W4387473447 isParatext "false" @default.
- W4387473447 isRetracted "false" @default.
- W4387473447 workType "article" @default.